Sonoma Pharmaceuticals SNOA
NASDAQ SNOA
$1.23 -0.02 (-1.60%)
At close: Oct 2, 2026 · 4:00 PM EDT

Sonoma Pharmaceuticals (SNOA) Gains from Sales and Divestitures (2010 - 2022)

Updated

Sonoma Pharmaceuticals (SNOA) recorded Gains from Sales and Divestitures of $1,000 in FY2023 (year ended Mar 31, 2023).

Analysis

Sonoma Pharmaceuticals (SNOA) Gains from Sales and Divestitures (2010 - 2022) Analysis & Trends

Starting with FY2011, Sonoma Pharmaceuticals' Gains from Sales and Divestitures history includes 8 fiscal years.

  • The FY2023 figure is the lowest annual Gains from Sales and Divestitures since FY2019.
  • Per Business Quant data, SNOA's Gains from Sales and Divestitures was $770,000 in FY2021 (-78.4%), $3.57 million in FY2020 and -$21,000 in FY2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 242.18 Bn 221.33 Bn 4.88 Bn
2 Abbott Laboratories 168.71 Bn 139.79 Bn 7.27 Bn
3 Danaher 150.46 Bn 134.27 Bn 3.61 Bn
4 Intuitive Surgical 138.71 Bn 118.26 Bn 1.96 Bn
5 Medtronic 110.54 Bn 76.41 Bn 6.34 Bn
6 Stryker 105.66 Bn 91.78 Bn 4.50 Bn
7 Boston Scientific 61.74 Bn 56.75 Bn 3.85 Bn
8 Edwards Lifesciences 49.09 Bn 33.21 Bn 1.35 Bn
9 Becton Dickinson 48.16 Bn 45.31 Bn 2.32 Bn
10 Sonoma Pharmaceuticals 4.73 Mn -8.60 Mn 2.58 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 1,000.00
Mar 31, 2022 -150,000.00
Sep 30, 2020 -102,000.00
Jun 30, 2020 872,000.00
Mar 31, 2020 3.57 Mn
Mar 31, 2019 -21,000.00
Mar 31, 2017 493,000.00
Jun 30, 2014 13,000.00
Mar 31, 2011 154,000.00
Jun 30, 2010 -4,000.00
API Access

Sonoma Pharmaceuticals Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=SNOA&period=max&api_key=YOUR_API_KEY